Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

biOasis Technologies Ord Shs V.BTI.H

Alternate Symbol(s):  BIOAF

Bioasis Technologies Inc. is a Canada-based biopharmaceutical company focused on research and development of technologies and products intended for the treatment of patients with nervous system, including central nervous system, diseases and disorders. The Company is engaged in the development of its xB 3 platform, which is a peptide-based technology, for the transport of therapeutic agents, in particular biological products, across the blood-brain barrier (BBB). It is focused on both orphan drug indications, including brain cancers, and rare genetic neurodegenerative diseases and neuroinflammatory conditions. The Company is also focused on its Epidermal Growth Factor (EGF) platform for treating rare and orphan neurodegenerative and neuroinflammatory disorders. EGF is a protein that stimulates cell growth and differentiation, notably for myelin producing cells. Its development programs include xB3-001: Brain Metastases, xB3-002: Glioblastoma and xB3-007: Neurodegenerative Disease.


TSXV:BTI.H - Post by User

Post by Sinbobon Jan 22, 2013 6:23pm
281 Views
Post# 20874669

Chart fluff

Chart fluff

For those tha look at the charts:

BTI closed today at $1.51… about where it bottomed Dec. 28th, and Dec. 21st. … approximately where it corrected to after a run from $1.23 on Jul. 23rd to $2.04 on Sept. 11th.  So, the slow consolidation before any news should be steady around this $1.50 to $1.70 range. BTI is trading just above its 200 day moving average of $1.50 and remains long term bullish since last summer. Closest bullish target is $1.75 and closest bearish target is $1.30.

The last few major ‘sells’ were in the 150,00 to 180,000 volume area near the $1.55 mark. Today’s sell volume was 117,000 between $1.60 and $1.50. Of course ‘someone’ bought those shares and most were sold by good old ‘anonymous’... which could mean anything.

$1.50 would appear to be a great buy here on imminent news.  Buying has appeared at this level in the past… and BTI is that much closer to news. Any opportunity to buy in this area or lower would be considered a time/buy opportunity.

There are no fundamental reasons to sell here as the Co. is tightly held by insiders with over 50% of the 40 million shares. I have no recent information on the short position, or any insider buying/selling.

News can be expected at any time over the next few weeks or so which could mean all of the above could be rendered meaningless... hard to predict exactly when and no rumours abound... a good thing.

Bullboard Posts